XML 18 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Net loss $ (2,556,476) $ (470,551)
Depreciation and amortization 308,084 376,920
Amortization of deferred gain on sale/leaseback (27,474)
Provision for losses on accounts receivable 6,085 (28,486)
Provision for losses on inventories (10,656) (17,781)
Impairment of long-lived assets 1,253,176 (35,503)
Deferred income taxes (133,982)
Stock based compensation 28,967 61,975
Change in assets and liabilities:    
Accounts receivable 660,299 (465,865)
Inventories (827,084) (1,995,477)
Prepaid expenses and other assets (20,233) 109,567
Trade payables 2,000,334 1,572,804
Accrued liabilities (149,957) 127,038
Net cash provided by (used in) operating activities 665,065 (899,341)
Cash flows from investing activities:    
Purchases of property, plant and equipment (52,243) 63,533
Net cash provided by (used in) investing activities (52,243) 63,533
Cash flows from financing activities:    
Change in checks written in excess of bank balance 18,504 (442,992)
Net change in revolving line of credit (1,235,126) 2,123,582
Repayment of long-term debt (213,521) (432,942)
Cash paid for deferred financing fees (27,585) (24,568)
Proceeds from issuance of long-term note payable (27,585)
Net cash provided by (used in) financing activities (807,728) 1,223,080
Effect of exchange rate changes on cash (57,802) 27,307
Net increase/(decrease) in cash and cash equivalents (252,708) 414,579
Cash and cash equivalents at beginning of period 428,150 181,026
Cash and cash equivalents at end of period 175,442 595,605
Supplemental disclosure of cash flow information:    
Cash payments for interest 366,688 $ 408,001
Conversion from Notes Payable To Common Stock [Member]    
Supplemental disclosure of cash flow information:    
Common stock issued for notes payable $ 600,000